Health Equity

All of Us aims to collect and study health data from at least a million people in the U.S. to advance precision medicine. The program's CEO, Josh Denny discusses the role of electronic health records, how the program protects participant privacy and, most recently, how the program is pivoting efforts to make discoveries about COVID-19....

COVID-19 vaccine development presents an opportunity to break down barriers to the engagement of Black and Latinx individuals in clinical trials research. Ideally, vaccine trials should include participants from communities that have the highest risk of infection. In the case of COVID-19, those at-risk communities are disproportionately Black and Latinx....

The All of Us Research Program, part of the National Institutes of Health, today announced that it is leveraging its significant and diverse participant base to seek new insights into COVID-19—through antibody testing, a survey on the pandemic’s impacts and collection of electronic health record information....